Showing results (301-310 of 542) with videos related to
Sort By:
Pageof 55
Archives of Disease in Childhood|December 18, 2016
Ethnic and socioeconomic variation in incidence of congenital heart defectsRachel L Knowles, Deborah Ridout, Sonya Crowe, et al.Current Oncology (Toronto, Ont.)|June 25, 2025
Ablative Techniques for Lung Metastases: Patient Selection and Outcomes Following Treatment with Stereotactic Radiotherapy or Radiofrequency AblationJennifer W S Pang, Daniel Tong, Nicos Fotiadis, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 16, 2015
Activity and outcomes for aortic valve implantations performed in England and Wales since the introduction of transcatheter aortic valve implantationStuart W Grant, Graeme L Hickey, Peter Ludman, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|December 21, 2018
Exercise intensity affects acute neurotrophic and neurophysiological responses poststrokePierce Boyne, Colleen Meyrose, Jennifer Westover, et al.Journal for Immunotherapy of Cancer|December 17, 2025
Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1Gary Middleton, Charlotte Gaskell, Joshua Savage, et al.International Journal of Cancer|December 31, 2013
Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancerMaressa A Bruhn, Amanda R Townsend, Chee Khoon Lee, et al.The Journal of Thoracic and Cardiovascular Surgery|March 11, 2008
Bleeding in cardiac surgery: the use of aprotinin does not affect survivalDomenico Pagano, Neil J Howell, Nick Freemantle, et al.The Lancet. Oncology|February 18, 2017
Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trialRobert Glynne-Jones, David Sebag-Montefiore, Helen M Meadows, et al.British Journal of Haematology|July 5, 2020
FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective studyN George Mikhaeel, David Cunningham, Nicholas Counsell, et al.Journal of the American Heart Association|May 22, 2016
Death and Emergency Readmission of Infants Discharged After Interventions for Congenital Heart Disease: A National Study of 7643 Infants to Inform Service ImprovementSonya Crowe, Deborah A Ridout, Rachel Knowles, et al.Pageof 55